The latest from the Initiative.

In this op-ed from Initiative founder Mike Zuendel, he addresses the need for change - and the opportunity he found in a diagnosis of Alzheimer’s disease.

Phasing out the ‘D-word’ - STAT

Mike Zuendel speaks about his experience with new anti-amyloid treatments for Alzheimer’s disease.

For Patients on Discontinued Aduhelm, What Now? - Being Patient